Actively Recruiting
Quality Of Life and Drug Use in Patients With CAR-T Cells
Led by Hospices Civils de Lyon · Updated on 2026-01-28
70
Participants Needed
1
Research Sites
617 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
CAR-T cells are a major therapeutic innovation in the management of patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL) in 3rd line or more. Kymriah® and Yescarta® are the first CAR-T with Marketing Authorization and coverage by the French Health Insurance. Their clinical interest has been demonstrated in non-comparative phase 1-2 trials. The non-comparative design of the pivotal trials, the lack of data on patients' quality of life and drug consumption, as well as the very high cost of CAR-T (about € 320,000 for one treatment) warrant further studies. This prospective non-comparative study aims to describe in real life the quality of life of patients treated with CAR-T cells, real world drug use and patients' experience feedback.
CONDITIONS
Official Title
Quality Of Life and Drug Use in Patients With CAR-T Cells
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years old
- Eligible for treatment with CAR-T cells (outside any clinical trial) for diffuse large B-cell lymphoma and scheduled for treatment
- Receiving follow-up care in the Hematology department of the Hospices Civils de Lyon
- No major psychiatric disorder likely to interfere with study participation, as judged by the investigator
- Provided non-opposition consent to participate in the study
You will not qualify if you...
- Living in an institution
- Under legal protection or guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospices Civils de Lyon -Groupement Hospitalier Sud Service pharmaceutique, Unité de Pharmacie Clinique Oncologique
Pierre-Bénite, France, 69495
Actively Recruiting
Research Team
C
Catherine RIOUFOL, Pharm. D
CONTACT
V
Vérane SCHWIERTZ, Pharm. D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here